Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors.
Middelburg J, Sluijter M, Schaap G, Göynük B, Lloyd K, Ovcinnikovs V, Zom GG, Marijnissen RJ, Groeneveldt C, Griffioen L, Sandker GGW, Heskamp S, van der Burg SH, Arakelian T, Ossendorp F, Arens R, Schuurman J, Kemper K, van Hall T. Middelburg J, et al. Among authors: van der burg sh. Nat Commun. 2024 Jan 2;15(1):48. doi: 10.1038/s41467-023-44308-6. Nat Commun. 2024. PMID: 38167722 Free PMC article.
Strategies for immunotherapy of cancer.
Melief CJ, Toes RE, Medema JP, van der Burg SH, Ossendorp F, Offringa R. Melief CJ, et al. Among authors: van der burg sh. Adv Immunol. 2000;75:235-82. doi: 10.1016/s0065-2776(00)75006-1. Adv Immunol. 2000. PMID: 10879286 Review. No abstract available.
Importance of CD4(+) T helper cell responses in tumor immunity.
Ossendorp F, Toes RE, Offringa R, van der Burg SH, Melief CJ. Ossendorp F, et al. Among authors: van der burg sh. Immunol Lett. 2000 Sep 15;74(1):75-9. doi: 10.1016/s0165-2478(00)00252-2. Immunol Lett. 2000. PMID: 10996631 Review. No abstract available.
Antitumor efficacy of wild-type p53-specific CD4(+) T-helper cells.
Zwaveling S, Vierboom MP, Ferreira Mota SC, Hendriks JA, Ooms ME, Sutmuller RP, Franken KL, Nijman HW, Ossendorp F, Van Der Burg SH, Offringa R, Melief CJ. Zwaveling S, et al. Among authors: van der burg sh. Cancer Res. 2002 Nov 1;62(21):6187-93. Cancer Res. 2002. PMID: 12414646
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells.
Khan S, Bijker MS, Weterings JJ, Tanke HJ, Adema GJ, van Hall T, Drijfhout JW, Melief CJ, Overkleeft HS, van der Marel GA, Filippov DV, van der Burg SH, Ossendorp F. Khan S, et al. Among authors: van der marel ga, van hall t, van der burg sh. J Biol Chem. 2007 Jul 20;282(29):21145-59. doi: 10.1074/jbc.M701705200. Epub 2007 Apr 26. J Biol Chem. 2007. PMID: 17462991 Free article.
Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells.
Khan S, Weterings JJ, Britten CM, de Jong AR, Graafland D, Melief CJ, van der Burg SH, van der Marel G, Overkleeft HS, Filippov DV, Ossendorp F. Khan S, et al. Among authors: van der burg sh, van der marel g. Mol Immunol. 2009 Mar;46(6):1084-91. doi: 10.1016/j.molimm.2008.10.006. Epub 2008 Nov 22. Mol Immunol. 2009. PMID: 19027958
340 results